Clinical Research Directory
Browse clinical research sites, groups, and studies.
Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2
Sponsor: Institut Claudius Regaud
Summary
This is an interventional, prospective, single-center study designed to collect and describe genetic, environmental and psychosocial control data from male participants. The participants did not have any prior history of cancer at the time of the oncogenetic consultation and do not have the family mutation researched during the oncogenetic consultation (targeted genetic testing). The participants are referenced in the IUCT-O medical records as family members of patients suffering from male breast cancer. The study will be conducted on a population of 120 participants.
Key Details
Gender
MALE
Age Range
66 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-10-15
Completion Date
2027-10-15
Last Updated
2026-08-19
Healthy Volunteers
No
Conditions
Interventions
Questionnaire completion
In order to meet the study's objective, after written informed consent was obtained, participants will be asked to complete a questionnaire characterizing their environmental and psychosocial context. The questionnaire is to be filled out by the participants at home. It is estimated that the questionnaire will take around 30 minutes to complete. Demographics data will also be collected from the medical records of included participants.
Genetic analysis (WES)
In order to meet the study's objective, after completion of the questionnaire, a genetic analysis (Whole Exome Sequencing) will be conducted on an archived blood sample collected during the initial oncogenetics consultation. The patient had given consent to this sample in order for the oncogenetics laboratory to perform the targeted genetic analysis (presence of family mutation). No additional blood sample will be collected for the purpose of this study.
Locations (1)
Institut Universitaire du Cancer Toulouse - Oncopole, Laboratoire d'oncogénétique
Toulouse, France